SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
05-Jun-23 4:31 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Jun-23 | Grant | 32,362 | -- | -- | 129% 25.08K to 57.44K | |
19-Jul-22 5:13 PM View: | Cara Therapeutics, Inc. (CARA) | 15-Jul-22 | Sale (Planned) | 7,200 | $9.05 | $65,160.00 | (22%) 32.28K to 25.08K | |
06-Jun-22 5:50 PM View: | Cara Therapeutics, Inc. (CARA) | 02-Jun-22 | Grant | 11,876 | -- | -- | 58% 20.4K to 32.28K | |
07-Jun-21 7:24 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Jun-21 | Grant | 7,200 | -- | -- | 55% 13.2K to 20.4K | |
08-Jun-20 5:48 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Jun-20 | Grant | 7,200 | -- | -- | 120% 6.0K to 13.2K | |
06-Jun-19 6:00 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Jun-19 | Grant | 6,000 | -- | -- | 100% 0 to 6.0K | |
04-Mar-04 10:00 PM View: | Bristol-Myers Squibb Co. (BMY) | 02-Mar-04 | Grant | 4,167 | -- | -- | 6% 66.48K to 70.65K | |
02-Mar-04 10:00 PM View: | Bristol-Myers Squibb Co. (BMY) | 01-Mar-04 | Payment of Exercise | 1,790 | $28.04 | $50,191.60 | (3%) 68.28K to 66.48K | (168%) |